{"id":"W2127435768","doi":"10.1586/erc.11.21","title":"Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial","year":2011,"lang":"en","type":"article","venue":"Expert Review of Cardiovascular Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Dabigatran; Warfarin; Atrial fibrillation; Stroke (engine); Rivaroxaban; Cardiology; Internal medicine; Discovery and development of direct thrombin inhibitors; Embolism; Anesthesia; Randomized controlled trial; Direct thrombin inhibitor; Thrombin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001877781,0.0001621262,0.000863908,0.00007481245,0.00004969161,0.00000795715,0.0001234159,0.00007247738,0.0001929521],"category_scores_gemma":[0.0001668163,0.0001019009,0.003464056,0.0002187735,0.00004350102,0.00009789514,0.00001739749,0.00006339197,0.000004636951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003007516,"about_ca_system_score_gemma":0.00005851267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003218995,"about_ca_topic_score_gemma":0.000001499307,"domain_scores_codex":[0.9982145,0.0002767315,0.0006552887,0.0002359448,0.0004596658,0.000157801],"domain_scores_gemma":[0.9989321,0.00009460076,0.0001732055,0.0006517225,0.0001107819,0.00003761456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0236889,0.0000225329,0.001271219,0.00152123,0.004952972,0.000005156962,0.001010553,0.000036744,0.0001739026,0.0008252119,0.001756931,0.9647347],"study_design_scores_gemma":[0.03921223,0.0006442646,0.001255244,0.001096608,0.0004649647,0.000004491957,0.00007495788,0.00001585382,0.0008216831,0.0002187291,0.9560466,0.0001443958],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01523192,0.9647846,0.004111115,0.002633753,0.001206887,0.009693313,0.000004685844,0.00004934926,0.002284345],"genre_scores_gemma":[0.06470793,0.9174464,0.006162251,0.0007724017,0.009840638,0.0001012151,0.00008225425,0.00006572242,0.0008211851],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9645903,"threshold_uncertainty_score":0.4155398,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1352088950558129,"score_gpt":0.3795011384208205,"score_spread":0.2442922433650076,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}